Cytokinetics
CYTK
#2426
Rank
A$10.50 B
Marketcap
A$85.90
Share price
-2.86%
Change (1 day)
25.70%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -A$1.17 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$87.21 Million. In 2024 the company made an earning of -A$0.84 Billion a decrease over its 2023 earnings that were of -A$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.17 Billion39.24%
2024 -A$0.84 Billion12.03%
2023 -A$0.75 Billion35.3%
2022 -A$0.56 Billion80.65%
2021 -A$0.31 Billion69.15%
2020 -A$0.19 Billion4.6%
2019 -A$0.18 Billion14.49%
2018 -A$0.16 Billion-16.83%
2017 -A$0.19 Billion-812.8%
2016 A$25.49 M-147.81%
2015 -A$53.33 Million156.05%
2014 -A$20.83 Million-56.56%
2013 -A$47.95 Million-16.48%
2012 -A$57.41 Million-15.65%
2011 -A$68.06 Million-3.24%
2010 -A$70.34 Million-308.68%
2009 A$33.7 M-141.87%
2008 -A$80.49 Million0.21%
2007 -A$80.32 Million-7.91%
2006 -A$87.22 Million37.42%
2005 -A$63.47 Million16.13%
2004 -A$54.65 Million-19.29%
2003 -A$67.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.72 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$44.16 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$94.97 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.27 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA